- Home
- VINP vs CRMD Comparison
VINP vs CRMD Comparison
Compare VINP & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VINP
- CRMD
- Stock Information
- Founded
- VINP 2009
- CRMD 2006
- Country
- VINP Brazil
- CRMD United States
- Employees
- VINP N/A
- CRMD N/A
- Industry
- VINP Investment Managers
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- VINP Finance
- CRMD Health Care
- Exchange
- VINP Nasdaq
- CRMD Nasdaq
- Market Cap
- VINP 593.2M
- CRMD 877.5M
- IPO Year
- VINP 2021
- CRMD 2010
- Fundamental
- Price
- VINP $9.49
- CRMD $11.28
- Analyst Decision
- VINP Strong Buy
- CRMD Strong Buy
- Analyst Count
- VINP 2
- CRMD 7
- Target Price
- VINP $13.25
- CRMD $17.33
- AVG Volume (30 Days)
- VINP 58.3K
- CRMD 2.2M
- Earning Date
- VINP 08-06-2025
- CRMD 08-13-2025
- Dividend Yield
- VINP 6.87%
- CRMD N/A
- EPS Growth
- VINP N/A
- CRMD N/A
- EPS
- VINP 0.38
- CRMD 0.28
- Revenue
- VINP $126,696,258.00
- CRMD $82,553,827.00
- Revenue This Year
- VINP $70.28
- CRMD $238.38
- Revenue Next Year
- VINP $14.37
- CRMD $53.52
- P/E Ratio
- VINP $24.85
- CRMD $40.46
- Revenue Growth
- VINP 57.51
- CRMD N/A
- 52 Week Low
- VINP $8.66
- CRMD $3.61
- 52 Week High
- VINP $11.62
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- VINP 45.90
- CRMD 39.54
- Support Level
- VINP $9.20
- CRMD $11.13
- Resistance Level
- VINP $9.94
- CRMD $11.86
- Average True Range (ATR)
- VINP 0.22
- CRMD 0.65
- MACD
- VINP -0.01
- CRMD -0.34
- Stochastic Oscillator
- VINP 39.46
- CRMD 3.81
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.